المنشورات

FOI.ICB-2526/157: Bevacizumab Gamma (Lytenava®) for Neovascular (wet) Age-related Macular Degeneration (NICE TA1022)

FOI.ICB-2526/100: Wound Care Services

FOI.ICB-2526/136: Commissioning and provision of Structured Diabetes Education (SDE) for people living with Type 1, Type 2 and Gestational Diabetes

FOI.ICB-2526/153: Guidance on Prams at GP Practices

FOI.ICB-2526/149: Primary Care Rebate Schemes

FOI.ICB-2526/152: Budget for Tobacco Dependence Treatment Services for 2025/26

FOI.ICB-2526/146: GP and Choose and Book Data

FOI.ICB-2526/133: Children’s ADHD Waiting Times

FOI.ICB-2526/124: Children and Young People (CYP) Autism Spectrum Disorder (ASD) Assessment Service and Diagnosis Support Services

FOI.ICB-2526/119: ICB-Commissioned Clinical Nursing Services in Educational Settings

FOI.ICB-2526/053: GP Prescribing Quality Scheme/Prescribing Incentive Scheme

FOI.ICB-2526/123: ADHD and Autism Assessments and Post-diagnostic Services